MANUFACTURERS' POINT OF VIEW ON MEDICAL PATENTS IN RELATION TO PUBLIC WELFARE
A. W. LESCOHIER, M.D. President, Parke, Davis & Co DetroitWhile listed on the program as presenting the manufacturers' point of view on medical patents in relation to public welfare, I wish to make it clear at the start that I am not undertaking to speak for the pharmaceutic industry. The majority of manufacturers might or might not agree with my views as expressed, which are purely personal but naturally based on such experience as I have had in the industry.I presume that the motive underlying the calling of this conference has to do less with the advantages or disadvantages of our patent system than it does with the policy which should be encouraged, particularly in medical schools, with regard to their securing and owning patents and their administration when secured and owned.However, one can hardly divorce these specific questions from the general philosophy of the patent system. The general aspects of the patent situation and the relation of patents to social and economic progress have been discussed
ORGANIZATION SECTION. JAMA. 1939;113(5):419–429. doi:10.1001/jama.1939.02800300049017
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: